1,295
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital

ORCID Icon, ORCID Icon &
Pages 2201-2212 | Published online: 14 Jun 2021

References

  • Coates AR, Halls G, Hu Y. Novel classes of antibiotics or more of the same? Br J Pharmacol. 2011;163(1):184–194. doi:10.1111/j.1476-5381.2011.01250.x21323894
  • Blair JM, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51. doi:10.1038/nrmicro338025435309
  • Molton JS, Tambyah PA, Ang BS, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56(9):1310–1318. doi:10.1093/cid/cit02023334810
  • Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12):122–129. doi:10.1038/nm1145
  • Kourtis AP, Hatfield K, Baggs J, et al. Emerging Infections Program MRSA Author Group: vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections-United States. MMWR Morb Mortal Wkly Rep. 2019;68:214–219. doi:10.15585/mmwr.mm6809e130845118
  • Khanal LK, Jha BK. Prevalence of methicillin resistant Staphylococcus aureus (MRSA) among skin infection cases at a hospital in Chitwan, Nepal. Nepal Med College J. 2010;12:224–228.
  • Mishra SK, Rijal BP, Pokhrel BM. Emerging threat of multidrug resistant bugs–Acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus. BMC Res Notes. 2013;6(1):98–103. doi:10.1186/1756-0500-6-9823497675
  • Mishra SK, Acharya J, Kattel HP, et al. Metallo-beta-lactamase producing gram-negative bacterial isolates. J Nepal Health Res Counc. 2012;10(22):208–213.23281453
  • Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11:297–308. doi:10.1586/eri.13.1223458769
  • Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–2. doi:10.1086/59501119035777
  • Shrestha S, Tada T, Miyoshi-Akiyama T, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents. 2015;46(5):526–531. doi:10.1016/j.ijantimicag.2015.07.01226362951
  • Browne K, Chakraborty S, Chen R et al. A new era of antibiotics: the clinical potential of antimicrobial peptides. Int J Mol Sci. 2020;21(19):7047.
  • Mishra SK, Basukala P, Basukala O, et al. Detection of biofilm production and antibiotic resistance pattern in clinical isolates from indwelling medical devices. Curr Microbiol. 2015;70:128–134. doi:10.1007/s00284-014-0694-525239012
  • Praharaj I, Sujatha S, Parija SC. Phenotypic & genotypic characterization of vancomycin resistant Enterococcus isolates from clinical specimens. Indian J Med Res. 2013;138:549–565.24434263
  • Isenberg HD, Garcia LS. Microbiological Techniques & Methods-Laboratory Manuals. Clinical Microbiology Procedures Handbook. 2nd ed. Washingtn DC; 2007:36–446.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. M100S: Wayne, Pennsylvania; 2016. 26th ed. 100–121.
  • Magiorakos A, Srinivasan A, Carey RB, et al. Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Tamma PD, Girdwood SC, Gopaul R, et al. The use of cefepime for treating AmpC β-lactamase–producing Enterobacteriaceae. Clin Infect Dis. 2013;57:781–788. doi:10.1093/cid/cit39523759352
  • Garrec H, Drieux-Rouzet L, Golmard JL, et al. Comparison of nine phenotypic methods for detection of extended-spectrum β-lactamase production by enterobacteriaceae. J Clin Microbiol. 2011;49:1048–1057. doi:10.1128/JCM.02130-1021248086
  • Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-β-lactamase- producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol. 2006;44:3139–3144. doi:10.1128/JCM.00879-0616954239
  • Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22:996–1006. doi:10.1128/jcm.22.6.996-1006.19853905855
  • Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol. 2006;24:25–29. doi:10.4103/0255-0857.1989016505551
  • Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 2001.
  • Akpaka PE, Kissoon S, Jayaratne P, et al. Genetic characteristics and molecular epidemiology of vancomycin-resistant Enterococci isolates from Caribbean countries. PLoS One. 2017;12:1–11. doi:10.1371/journal.pone.0185920
  • Peter A, Zacharia S, Mathew EKR. Antimicrobial resistance trends with special reference to vancomycin resistance among different species of enterococci. Int J Pharma Bio Sci. 2013;4:356–363.
  • Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016;2016:1–8. doi:10.1155/2016/2475067
  • Parajuli NP, Acharya SP, Mishra SK, et al. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6:1–9. doi:10.1186/s13756-017-0222-z
  • World Health Organization. Antimicrobial resistance: global report on surveillance. World Health Organization; 2014:383–394.
  • WHO priority pathogens list for R&D of new antibiotics; 2017. Available from: https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 626, 2019.
  • Pandeya U, Raut M, Bhattarai S, Bhatt PR, Dahal PR. Bacteriological Profile and antibiogram of Bacterial Isolates from pus samples in tertiary care hospital of Kathmandu, Tribhuvan University. J Microbiol. 2018;4(1):55–62. doi:10.3126/tujm.v4i0.21678
  • Mishra SK, Kattel HP, Acharya J, et al. Recent trend of bacterial aetiology of lower respiratory tract infection in a tertiary care centre of Nepal. Int J Infect Microbiol. 2012;1:3–8. doi:10.3126/ijim.v1i1.6639
  • Ansari S, Nepal HP, Gautam R, et al. Childhood septicemia in Nepal: documenting the bacterial etiology and its susceptibility to antibiotics. Int J Microbiol. 2014:1–6. doi:10.1155/2014/452648.
  • Parajuli NP, Parajuli H, Pandit R, Shakya J, Khanal PR. Evaluating the trends of bloodstream infections among pediatric and adult patients at a teaching hospital of Kathmandu, Nepal: role of drug resistant pathogens. Can J Infect Dis Med Microbiol. 2017;1–10. doi:10.1155/2017/8763135
  • Sanjana RK, Shah R, Chaudhary N, Singh YI. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) in CMS-teaching hospital: a preliminary report. J Coll Med Sci Nepal. 2010;6:1–6. doi:10.3126/jcmsn.v6i1.3595
  • Willems RJ, Top J, Marga van Santen D, et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis. 2005;11:821–828. doi:10.3201/eid1106.04120415963275
  • Amatya R, Jha B, Shrestha S, Adhikari RP, Timsina S. Prevalence of high level gentamicin and vancomycin resistance among clinical isolates of enterococci from a tertiary care hospital in central Nepal. Nepal Med College J. 2014;16:125–127.
  • Acharya A, Khanal A, Kanungo R, Mohapatra T. Characterization and susceptibility patterns of clinically important Enterococcus species in eastern Nepal. Nepal Med College J. 2007;9:250–254.
  • Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother. 1995;39:1772–1778. doi:10.1128/AAC.39.8.17727486917
  • Ko KS, Baek JY, Lee J, et al. Molecular characterization of vancomycin-resistant Enterococcus faecium Isolates from Korea Molecular characterization of vancomycin-resistant Enterococcus faecium Isolates from Korea. J Clin Microbiol. 2005;43:2303–2306. doi:10.1128/JCM.43.5.2303-2306.200515872259
  • Llaca-Díaz JM, Mendoza-Olazarán S, Camacho-Ortiz A, Flores S, Garza-González E. One-year surveillance of eskape pathogens in an intensive care unit of monterrey, Mexico. Chemotherapy. 2012;58:475–481. doi:10.1159/00034635223548324
  • Mehta A, Rosenthal VD, Mehta Y, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007;67:168–174. doi:10.1016/j.jhin.2007.07.00817905477
  • Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005;11:17–32. doi:10.1111/j.1469-0691.2005.01161.x
  • Pathak P, Jaishi N, Yadav BK, Shah PK. Prevalence of Extended Spectrum Beta Lactamases (ESBL) and Metallo Beta Lactamases (MBL) mediated resistance in gram negative bacterial pathogens. Tribhuvan Univ J Microbiol. 2017;4(1):49–54. doi:10.3126/tujm.v4i0.21677
  • Raut S, Gokhale S, Adhikari B. Prevalence of Extended Spectrum Beta-Lactamases among Escherichia coli and Klebsiella spp isolates in Manipal Teaching Hospital, Pokhara, Nepal. J Microbiol Infect Dis. 2015;5(2):69–75. doi:10.5799/ahinjs.02.2015.02.0179
  • Nepal K, Pant ND, Neupane B, Belbase A, Baidhya R, Shrestha RK. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal. Ann Clin Microbiol Antimicrob. 2017;16:1–7. doi:10.1186/s12941-017-0236-728061852
  • Bhandari P, Thapa G, Pokhrel BM, Bhatta DR, Devkota U. Nosocomial isolates and their drug resistant pattern in ICU patients at national institute of neurological and allied sciences, Nepal. Int J Microbiol. 2015;1:1–6. doi:10.1155/2015/572163
  • Evans B, Amyes S. Oxa ß-lactamase. Clin Microbiol Rev. 2014;27:241–263. doi:10.1128/CMR.00117-1324696435
  • Bedenić B, Ladavac R, Vranić-Ladavac M, et al. False positive phenotypic detection of metallo-beta-lactamases in Acinetobacter baumannii. Acta clinica Croatica. 2019;58:113–118. doi:10.20471/acc.2019.58.01.1531363333
  • Chu H, Zhao L, Wang M, Liu Y, Gui T, Zhang J. Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis. Braz J Infect Dis. 2013;17:389–394. doi:10.1016/j.bjid.2012.10.02923602463
  • Penwell WF, Shapiro AB, Giacobbe RA, et al. Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. Antimicrob Agents Chemother. 2015;59:1680–1689. doi:10.1128/AAC.04808-1425561334
  • Shashwati N, Kiran T, Dhanvijay A. Study of extended spectrum β-lactamase producing Enterobacteriaceae and antibiotic coresistance in a tertiary care teaching hospital. J Nat Sci Biol Med. 2014;5:30. doi:10.4103/0976-9668.12728024678193
  • Ghimire S, Basnet HB, Joshi LR, Sapkota M. Prevalence of Vancomycin resistant enterococci species in minced buffalo meat of Chitwan, Nepal. Int J Appl Sci Biotechnol. 2014;2:409–412. doi:10.3126/ijasbt.v2i4.11123
  • Nepal HP, Khanal B, Sharma SK, Gyawali N, Jha PK, Paudel R. Peritonitis in a continuous ambulatory peritoneal dialysis patient by two different species of enterococci: a rare finding. Indian J Nephrol. 2014;24:324. doi:10.4103/0971-4065.13303025249726
  • Thapa R, Pant ND, Yadav UN, Thapa E, Singh A, Pokhrel BM. Isolation of multidrug resistant bacteria from patients medical charts. J Nepal Health Res Counc. 2017;15:146–149. doi:10.33314/jnhrc.v15i2.105329016585
  • Bhandari S, Banjara MR, Lekhak B, Bhatta DR, Regmi SR. Multi-drug and pan-drug resistant pseudomonas aeruginosa: a challenge in post- antibiotic era. Nepal J Sci Technol. 2013;13:197–202. doi:10.3126/njst.v13i2.7736
  • Van BTP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci. 112;5649–5654. doi:10.1073/pnas.1503141112
  • Centers for Disease Control and Prevention (CDC). Antibiotic/Antimicrobial Resistance, food and Food animals; 2018. Available from: https://www.cdc.gov/drugresistance/food.html. Accessed 620, 2020.
  • Madlen D, Stocktona B Health Ministry bans sale, distribution of antibiotic Colistin for food producing animals; 2019. Available from: https://www.thehindubusinessline.com/news/science/health-ministry-bans-sale-distribution-of-antibiotic-colistin-for-food-producing-animals/article28627093.ece. Accessed 721, 2019.
  • Cepas V, López Y, Munoz E, et al. Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria. Microbial Drug Resist. 2019;25:72–79. doi:10.1089/mdr.2018.0027
  • Sanchez CJ, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:1–12. doi:10.1186/1471-2334-13-4723280237
  • Vuotto C, Longo F, Balice M, Donelli G, Varaldo P. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2014;3:743–758. doi:10.3390/pathogens303074325438022